Gwendolyn Wrenn Baxter

Array ( [id] => 813358 [patent_doc_number] => 07413736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications' [patent_app_type] => utility [patent_app_number] => 11/828201 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8038 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/413/07413736.pdf [firstpage_image] =>[orig_patent_app_number] => 11828201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5112459 [patent_doc_number] => 20070196374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/560524 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30239 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196374.pdf [firstpage_image] =>[orig_patent_app_number] => 11560524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314960 [patent_doc_number] => 07524930 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 11/543065 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 16308 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524930.pdf [firstpage_image] =>[orig_patent_app_number] => 11543065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820704 [patent_doc_number] => 07408037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 11/543066 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 16307 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408037.pdf [firstpage_image] =>[orig_patent_app_number] => 11543066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798073 [patent_doc_number] => 07427660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 11/543087 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 16304 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427660.pdf [firstpage_image] =>[orig_patent_app_number] => 11543087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 821884 [patent_doc_number] => 07404270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 11/543088 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 16349 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/404/07404270.pdf [firstpage_image] =>[orig_patent_app_number] => 11543088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602591 [patent_doc_number] => 07432354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Tumor antigen' [patent_app_type] => utility [patent_app_number] => 11/543089 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 16292 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432354.pdf [firstpage_image] =>[orig_patent_app_number] => 11543089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148765 [patent_doc_number] => 20070048825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 11/538517 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 65976 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048825.pdf [firstpage_image] =>[orig_patent_app_number] => 11538517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856934 [patent_doc_number] => 07375193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 11/537015 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 30246 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375193.pdf [firstpage_image] =>[orig_patent_app_number] => 11537015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 869059 [patent_doc_number] => 07365166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 11/536603 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 30255 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365166.pdf [firstpage_image] =>[orig_patent_app_number] => 11536603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056380 [patent_doc_number] => 20070059302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/536588 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30253 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059302.pdf [firstpage_image] =>[orig_patent_app_number] => 11536588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857944 [patent_doc_number] => 20060228366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Tumor specific monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/413563 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25593 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228366.pdf [firstpage_image] =>[orig_patent_app_number] => 11413563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727751 [patent_doc_number] => 20060058512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Process for producing humanized chimera antibody' [patent_app_type] => utility [patent_app_number] => 11/228319 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20240 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058512.pdf [firstpage_image] =>[orig_patent_app_number] => 11228319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738066 [patent_doc_number] => 20060008456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Natural humanized antibody' [patent_app_type] => utility [patent_app_number] => 11/226325 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 24297 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008456.pdf [firstpage_image] =>[orig_patent_app_number] => 11226325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894825 [patent_doc_number] => 20060003364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'GLUT1 transporters expressed in cancer cells' [patent_app_type] => utility [patent_app_number] => 11/147111 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11460 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003364.pdf [firstpage_image] =>[orig_patent_app_number] => 11147111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894822 [patent_doc_number] => 20060003361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'SMVT transporters expressed in cancer cells' [patent_app_type] => utility [patent_app_number] => 11/146489 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11353 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003361.pdf [firstpage_image] =>[orig_patent_app_number] => 11146489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216847 [patent_doc_number] => 20050260212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/089872 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18913 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260212.pdf [firstpage_image] =>[orig_patent_app_number] => 11089872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996279 [patent_doc_number] => 20050136057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Antibodies against human parathyroid hormone related protein' [patent_app_type] => utility [patent_app_number] => 11/047996 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 36618 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136057.pdf [firstpage_image] =>[orig_patent_app_number] => 11047996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250167 [patent_doc_number] => 20050142137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Antibodies against secretoryleukocyte protease inhibitor' [patent_app_type] => utility [patent_app_number] => 10/984960 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20824 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142137.pdf [firstpage_image] =>[orig_patent_app_number] => 10984960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435638 [patent_doc_number] => 07261892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Methods for diagnosis and treatment of epithelial-derived cancers' [patent_app_type] => utility [patent_app_number] => 10/981381 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19351 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/261/07261892.pdf [firstpage_image] =>[orig_patent_app_number] => 10981381 [rel_patent_id] =>[rel_patent_doc_number] =>)